Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
An experienced CDMO partner with an extensive network makes the difference when it comes to scale-up, tech transfer capabilities, and validation. Paul Seaback, Senior VP of Technical Operations with Dermavant Sciences Inc., shares why they chose Thermo Fisher Scientific Patheon pharma services when transitioning from big pharma to the CDMO world.